The role of Bcl6 in mature cardiac myocytes

Cardiovascular Research

Volumn 42, Issue 3, 1999, Pages 670-679

  Yoshida, Takehiko ^a,b   Fukuda, Tetsuya ^a,d   Hatano, Masahiko ^a   Koseki, Haruhiko ^a   Okabe, Shin Ichiro ^a   Ishibashi, Kazuki ^a   Kojima, Satoko ^a   Arima, Masafumi ^a   Komuro, Issei ^c   Ishii, Genichiro ^a   Miki, Tohru ^d   Hirosawa, Shinsaku ^d   Miyasaka, Nobuyuki ^d   Taniguchi, Masaru ^a   Ochiai, Takenori ^b   Isono, Kaichi ^b   Tokuhisa, Takeshi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bcl6; Knockout mice; Myocaditis; Terminal differentiation; Tissue eosinophilia

Indexed keywords

TRANSCRIPTION FACTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL MATURATION; CONJUNCTIVA; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; FEMALE; GENE EXPRESSION; HEART MUSCLE CELL; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REPRESSOR GENE; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BONE MARROW TRANSPLANTATION; DNA-BINDING PROTEINS; EOSINOPHILIA; GENE DELETION; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; MYOCARDITIS; MYOCARDIUM; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANSCRIPTION FACTORS;

EID: 0033036131     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00007-3     Document Type: Article

References (35)

1. Bastard C., Deweindt C., Kerchaert J.P., et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome. Blood. 83:1994;2423-2427.
2. Lo Coco F., Ye B.H., Lista F., et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 83:1994;1757-1759.
3. Baron B.W., Nucifora G., McCabe N., Espinosa R. III, Le Beau M.M., McKeithan T.W. Identification of the gene associated with the recurring chromosomal translocation t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA. 90:1993;5262-5266.
4. Miki T., Kawamata N., Arai A., et al. Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood. 83:1994;217-222.
5. Cattoretti G., Chang C.C., Cechova K., et al. BCL-6 protein is expressed in germinal-center B cells. Blood. 86:1995;45-53.
6. Onizuka T., Moriyama M., Yamochi T., et al. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood. 86:1995;28-37.
7. Deweindt C., Albagli O., Bernardin F., et al. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ. 6:1995;1495-1503.
8. Chang C.C., Ye B.H., Chaganti R.S.K., Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci USA. 93:1996;6947-6952.
9. Seyfert V.L., Allman D., He Y., Staudt L.M. Transcriptional repression by the proto-oncogene BCL-6. Oncogene. 12:1996;2331-2342.
10. Fukuda T., Miki T., Yoshida T., et al. The murine BCL6 gene is induced in activated lymphocytes as an immediate early gene. Oncogene. 11:1995;1657-1663.
11. Yoshida T., Fukuda T., Okabe S., et al. The BCL6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage. Biochem Biophys Res Commun. 228:1996;216-220.
12. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 276:1997;589-592.
13. Ye B.H., Cattoretti G., Shen Q., et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Genet. 16:1997;161-170.
14. Fukuda T., Yoshida T., Okada S., et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med. 186:1997;439-448.
15. Dent L.A., Strath M., Mellor A.L., Sanderson C.J. Eosionphilia in transgenic mice expressing interleukin 5. J Exp Med. 172:1990;1425-1431.
16. Tominaga A., Takaki S., Koyama N., et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med. 173:1991;429-437.
17. Gleich G.J., Adolphson C.R. The eosinophilic leukocyte: structure and function. Adv Immunol. 39:1986;177-253.
18. Patella V., deCrescenzo G., Marino I., et al. Eosinophil granule proteins activate human heart mast cells. J Immunol. 157:1996;1219-1225.
19. Wood S.A., Allen N.D., Rossant J., Auerbach D., Nagy A. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature (Lond). 365:1993;87-89.
20. Yamamoto H., Hatano M., Iitsuka Y., Mahyar N., Yamamoto H., Tokuhisa T. Two forms of Hox11, a T cell leukemia oncogene, are expressed in fetal spleen but not in primary lymphocytes. Mol Immunol. 32:1995;1177-1182.
21. Luna L.C. Manual of histologic staining methods of the armed forces institute of pathology. 1968;McGraw-Hill Book Company, New York, NY.
22. Lyons G.E., Schiaffino S., Sassoon D., Barton P., Buckingham M. Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol. 111:1990;2427-2436.
23. DeVriese A.S., Kips J.C., Vogelaers D.P., Vandewoude K.H., Cuvelier C.A., Colardyn F.A. Pitfalls in the diagnosis of hypereosinophilic syndrome: a report of two cases. J Intern Med. 241:1997;165-170.
24. Ono N., Shimizu Y., Kasai A., et al. Eosinophilic heart disease with favorable courses: report of two cases. J Cardiol. 21:1991;171-181.
25. Fukunami M., Yellon D.M., Kudoh Y., Maxwell M.P., Wyse R.K., Hearse D.J. Spatial and temporal characteristics of the transmural distribution of collateral flow and energy metabolism during regional myocardial ischemia in the dog. Can J Cardiol. 3:1987;94-103.
26. Hardy W.R., Anderson R.E. The hypereosinophilic syndromes. Ann Intern Med. 68:1968;1220-1229.
27. Weyman A.E., Rankin R., King H. Loeffler's endocarditis presenting as mitral and tricuspid stenosis. Am J Cardiol. 40:1977;438-444.
28. Take M., Sekiguchi M., Hiroe M. Clinical spectrum and endomyocardial biopsy in eosinophilic heart disease. Heart Vessels. 1:1985;243-249.
29. Naito H., Nakatsuka M., Yuki K., Yamada H. Giant left ventricular thrombi in the hypereosinophilic syndrome: report of two cases. J Cardiogr. 16:1986;475-488.
30. Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., Williams T.J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 182:1995;1169-1174.
31. Rothenberg M.E., Ownbey R., Mehlhop P.D., et al. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med. 2:1996;334-348.
32. Li Y., Huang T-T, Carlson E.J., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 11:1995;376-381.
33. Marcia M.S., Ormsby I., Kier A.B., et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
34. Letterio J.J., Geiser A.G., Kulkarni A.B., Roche N.S., Sporn M.B., Roberts A.B. Maternal rescue of transforming growth factor-β1 null mice. Science. 264:1994;1936-1938.
35. Kumagai T., Miki T., Kikuchi M., et al. The proto-oncogene Bcl6 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells. Oncogene. 18:1999;467-475.